Supplementary Fig. 7 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation
Abstract
Supplementary Fig. 7: Comparative transcriptional pathway analysis of MTO and fulvestrant treatments
Fields of Study & Subjects
Melanoma and MAPK Pathways
Protein Degradation and Inhibitors
Mitochondrial Function and Pathology
Publication details
- Publisher
- American Association for Cancer Research (AACR)
- Publication date
- 2 January 2026